Comparison of High Dose and Low Dose Folic Acid Supplementation on Prevalence, Onset and Severity of Preeclampsia

Overview

Journal Adv Biomed Res

Specialty Biomedical Engineering

Date 2017 Feb 21

PMID 28217630

Citations 2

Authors

Azar Danesh Shahraki

Nastaran Zamani Dehkordi

Masoud Lotfizadeh

Affiliations

Soon will be listed here.

Abstract

Background: Folic acid supplementation had previously mentioned as a protective factor against the onset of preeclampsia (PE). In this study, we aimed to compare the effect of high dose (5 mg daily) and low dose (1 mg daily) of folic acid supplementation on prevalence, onset and severity of PE.

Materials And Methods: Pregnant women who were in the first trimester and referred to prenatal care university hospitals of Isfahan, Iran during October 2013-May 2015 were included in this study, then they were randomly divided into two groups of 5 mg and 1 mg (treated with daily 5 mg and 1 mg of folic acid, respectively), both groups received folic acid from the first trimester of pregnancy to 42 days after termination. Blood pressure, body mass index (BMI), and some urine and blood biochemistry parameters were measured. SPSS-22 used for statistical analysis.

Results: A total of 943 pregnant women participated in the study (450 women in 1 mg group and 450 women in 5 mg group). Incidence rate of PE was 3.8% in 1 mg group and 2.4% in 5 mg group. In a comparison of preeclamptic patients in 1 mg and 5 mg group, no significant differences were seen regarding age, BMI, laboratory data, the severity of the disease, and onset (early or late) ( > 0.05).

Conclusion: Although our findings support that administration of high dose folic acid may decrease the prevalence of PE, there is not enough data to support that higher amount of folic acid administration can reduce the severity of presentation's signs or ameliorate the laboratory data and the onset of PE.

Citing Articles

Preventive effects of folic acid on Zika virus-associated poor pregnancy outcomes in immunocompromised mice.

Simanjuntak Y, Ko H, Lee Y, Yu G, Lin Y PLoS Pathog. 2020; 16(5):e1008521.

PMID: 32392268 PMC: 7241851. DOI: 10.1371/journal.ppat.1008521.

Effect of high dose folic acid supplementation in pregnancy on pre-eclampsia (FACT): double blind, phase III, randomised controlled, international, multicentre trial.

Wen S, White R, Rybak N, Gaudet L, Robson S, Hague W BMJ. 2018; 362:k3478.

PMID: 30209050 PMC: 6133042. DOI: 10.1136/bmj.k3478.

References

Magnussen E, Vatten L, Davey Smith G, Romundstad P . Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol. 2010; 114(5):961-970. DOI: 10.1097/AOG.0b013e3181bb0dfc. View

Roberts J, Gammill H . Preeclampsia: recent insights. Hypertension. 2005; 46(6):1243-9. DOI: 10.1161/01.HYP.0000188408.49896.c5. View

Li Z, Ye R, Zhang L, Li H, Liu J, Ren A . Folic acid supplementation during early pregnancy and the risk of gestational hypertension and preeclampsia. Hypertension. 2013; 61(4):873-9. DOI: 10.1161/HYPERTENSIONAHA.111.00230. View

Cotter A, Molloy A, Scott J, Daly S . Elevated plasma homocysteine in early pregnancy: a risk factor for the development of nonsevere preeclampsia. Am J Obstet Gynecol. 2003; 189(2):391-4. DOI: 10.1067/s0002-9378(03)00669-0. View

Czeizel A, Dudas I . Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992; 327(26):1832-5. DOI: 10.1056/NEJM199212243272602. View

DAnna R, Baviera G, Corrado F, Ientile R, Granese D, Stella N . Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction. Acta Obstet Gynecol Scand. 2004; 83(2):155-8. DOI: 10.1111/j.0001-6349.2004.00291.x. View

MacKay A, Berg C, Atrash H . Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001; 97(4):533-8. DOI: 10.1016/s0029-7844(00)01223-0. View

Garovic V, Bailey K, Boerwinkle E, Hunt S, Weder A, Curb D . Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens. 2010; 28(4):826-33. PMC: 2980863. DOI: 10.1097/HJH.0b013e328335c29a. View

Sorensen T, MALINOW M, Williams M, King I, Luthy D . Elevated second-trimester serum homocyst(e)ine levels and subsequent risk of preeclampsia. Gynecol Obstet Invest. 1999; 48(2):98-103. DOI: 10.1159/000010148. View

10.

Cotter A, Molloy A, Scott J, Daly S . Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol. 2001; 185(4):781-5. DOI: 10.1067/mob.2001.117304. View

11.

Wen S, Chen X, Rodger M, White R, Yang Q, Smith G . Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol. 2008; 198(1):45.e1-7. DOI: 10.1016/j.ajog.2007.06.067. View

12.

Rumbold A, Crowther C, Haslam R, Dekker G, Robinson J . Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med. 2006; 354(17):1796-806. DOI: 10.1056/NEJMoa054186. View

13.

Bilano V, Ota E, Ganchimeg T, Mori R, Souza J . Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLoS One. 2014; 9(3):e91198. PMC: 3962376. DOI: 10.1371/journal.pone.0091198. View

14.

Bodnar L, Tang G, Ness R, Harger G, Roberts J . Periconceptional multivitamin use reduces the risk of preeclampsia. Am J Epidemiol. 2006; 164(5):470-7. DOI: 10.1093/aje/kwj218. View

15.

Campbell O, Graham W . Strategies for reducing maternal mortality: getting on with what works. Lancet. 2006; 368(9543):1284-99. DOI: 10.1016/S0140-6736(06)69381-1. View

16.

Mujawar S, Patil V, Daver R . Study of serum homocysteine, folic Acid and vitamin b(12) in patients with preeclampsia. Indian J Clin Biochem. 2012; 26(3):257-60. PMC: 3162959. DOI: 10.1007/s12291-011-0109-3. View

17.

Ray J, Laskin C . Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Placenta. 1999; 20(7):519-29. DOI: 10.1053/plac.1999.0417. View

18.

Onalan R, Onalan G, Gunenc Z, Karabulut E . Combining 2nd-trimester maternal serum homocysteine levels and uterine artery Doppler for prediction of preeclampsia and isolated intrauterine growth restriction. Gynecol Obstet Invest. 2005; 61(3):142-8. DOI: 10.1159/000090432. View

19.

Poston L, Briley A, Seed P, Kelly F, Shennan A . Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet. 2006; 367(9517):1145-54. DOI: 10.1016/S0140-6736(06)68433-X. View

20.

Flint A . Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry. 1994; 151(5):640-9. DOI: 10.1176/ajp.151.5.640. View